Annual Total Long Term Liabilities
$40.92 M
-$6.19 M-13.15%
December 31, 2024
Summary
- As of March 13, 2025, RNA annual total long term liabilities is $40.92 million, with the most recent change of -$6.19 million (-13.15%) on December 31, 2024.
- During the last 3 years, RNA annual total long term liabilities has risen by +$24.43 million (+148.11%).
- RNA annual total long term liabilities is now -73.09% below its all-time high of $152.03 million, reached on December 31, 2019.
Performance
RNA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$40.92 M
-$5.14 M-11.16%
December 31, 2024
Summary
- As of March 13, 2025, RNA quarterly total long term liabilities is $40.92 million, with the most recent change of -$5.14 million (-11.16%) on December 31, 2024.
- Over the past year, RNA quarterly long term liabilities has dropped by -$5.14 million (-11.16%).
- RNA quarterly long term liabilities is now -73.09% below its all-time high of $152.03 million, reached on December 31, 2019.
Performance
RNA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RNA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.2% | -11.2% |
| 3 y3 years | +148.1% | -11.2% |
| 5 y5 years | -73.1% | -11.2% |
RNA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.2% | +364.1% | -13.2% | +543.2% |
| 5 y | 5-year | -73.1% | +364.1% | -73.1% | +543.2% |
| alltime | all time | -73.1% | +364.1% | -73.1% | +543.2% |
Avidity Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $40.92 M(-13.1%) | $40.92 M(-11.2%) |
| Sep 2024 | - | $46.06 M(+9.2%) |
| Jun 2024 | - | $42.18 M(-7.5%) |
| Mar 2024 | - | $45.62 M(-3.2%) |
| Dec 2023 | $47.11 M(+434.3%) | $47.11 M(+575.0%) |
| Sep 2023 | - | $6.98 M(+9.7%) |
| Jun 2023 | - | $6.36 M(-8.8%) |
| Mar 2023 | - | $6.98 M(-20.9%) |
| Dec 2022 | $8.82 M | $8.82 M(-19.0%) |
| Sep 2022 | - | $10.89 M(-14.7%) |
| Jun 2022 | - | $12.76 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $14.51 M(-12.0%) |
| Dec 2021 | $16.49 M(+26.0%) | $16.49 M(+91.3%) |
| Sep 2021 | - | $8.62 M(-11.2%) |
| Jun 2021 | - | $9.71 M(-12.7%) |
| Mar 2021 | - | $11.12 M(-15.0%) |
| Dec 2020 | $13.09 M(-91.4%) | $13.09 M(+6.5%) |
| Sep 2020 | - | $12.29 M(-8.6%) |
| Jun 2020 | - | $13.44 M(-12.4%) |
| Mar 2020 | - | $15.34 M(-89.9%) |
| Dec 2019 | $152.03 M(+275.4%) | $152.03 M |
| Dec 2018 | $40.49 M | - |
FAQ
- What is Avidity Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Avidity Biosciences?
- What is Avidity Biosciences annual total long term liabilities year-on-year change?
- What is Avidity Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Avidity Biosciences?
- What is Avidity Biosciences quarterly long term liabilities year-on-year change?
What is Avidity Biosciences annual total long term liabilities?
The current annual total long term liabilities of RNA is $40.92 M
What is the all time high annual total long term liabilities for Avidity Biosciences?
Avidity Biosciences all-time high annual total long term liabilities is $152.03 M
What is Avidity Biosciences annual total long term liabilities year-on-year change?
Over the past year, RNA annual total long term liabilities has changed by -$6.19 M (-13.15%)
What is Avidity Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of RNA is $40.92 M
What is the all time high quarterly long term liabilities for Avidity Biosciences?
Avidity Biosciences all-time high quarterly total long term liabilities is $152.03 M
What is Avidity Biosciences quarterly long term liabilities year-on-year change?
Over the past year, RNA quarterly total long term liabilities has changed by -$5.14 M (-11.16%)